Ayman K M Hassan
Overview
Explore the profile of Ayman K M Hassan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
145
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Hassan A, Algowhary M, Kishk A, Youssef A, Razik N
Int J Cardiovasc Imaging
. 2020 Feb;
36(5):889-897.
PMID: 32016882
The mitral valve surgery decision is made mainly according to echocardiographic (ECHO) criteria. As the asymptomatic patients are still candidates for surgery in some situations, this makes the accurate assessment...
12.
Ahmed T, Abdel-Nazeer A, Hassan A, Hasan-Ali H, Youssef A
Ann Noninvasive Electrocardiol
. 2019 Feb;
24(4):e12637.
PMID: 30737993
Background: Arrhythmias are considered one of the major causes of death in ST elevation myocardial infarction (STEMI), particularly in the early in-hospital phase. Pre-infarction angina (PIA) has been suggested to...
13.
Hassan A, Mohamed H, Mohamed A, Ahmed T, Kishk Y
Egypt Heart J
. 2018 Dec;
70(4):421-426.
PMID: 30591766
No abstract available.
14.
Hassan A, Abd-El Rahman H, Hassan S, Ahmed T, Youssef A
Egypt Heart J
. 2018 Dec;
70(4):381-387.
PMID: 30591760
Background: Coronary tortuosity (CT) had different definitions and scores in literature with unclear pathophysiological impact. Objectives: To study degree of CT and it's relation to ischemic changes in patients with...
15.
Hassan A, Fouad D, Refaiy A
Egypt Heart J
. 2018 Apr;
69(1):29-35.
PMID: 29622952
Background: The diagnosis of myocarditis is still a challenge. The true incidence of the disease is unknown due to great variation in clinical manifestations. Objective: The aim of this study...
16.
El Desoky E, Hassan A, Salem S, Fadil S, Taha A
Int J Cardiol
. 2016 Aug;
222:866-873.
PMID: 27522390
Background: Atorvastatin and remote ischemic preconditioning (RIPC) have beneficial cardiovascular protective effects. The aim of the study was to investigate possible effect of this drug alone and in combination with...
17.
I Abdel-Aziz M, Ali M, Hassan A, Elfaham T
Saudi Pharm J
. 2015 Dec;
23(6):642-9.
PMID: 26702259
The objective of this study was to investigate the influence of simultaneous factors that potentially keep patients far from achieving target INR range at discharge in hospitalized patients. Prospective cross-sectional...
18.
I Abdel-Aziz M, Ali M, Hassan A, Elfaham T
J Clin Pharmacol
. 2015 Jul;
56(1):39-46.
PMID: 26138877
The objective of this study was to investigate the effect of polypharmacy and high doses of amoxicillin/clavulanate on warfarin response in hospitalized patients. This was a prospective cross-sectional observational study...
19.
Hassan A, Dimitry S, Agban G
PLoS One
. 2014 Jun;
9(6):e99035.
PMID: 24905094
Background: To assess the added value of the 6 minute walk test distance (6MWTD) in the risk-stratification methods for patients with ST -segment elevation myocardial infarction (STEMI) treated with fibrinolysis....
20.
Bergheanu S, van der Hoeven B, Hassan A, Dijkstra J, Rosendaal F, Liem S, et al.
Acta Cardiol
. 2010 Jan;
64(5):611-6.
PMID: 20058506
Objectives: Stent thrombosis is a life-threatening complication associated with sudden death and acute myocardial infarction. Histopathologic studies have linked the occurrence of very late stent thrombosis in drug-eluting stents (DES)...